StonvexLoading…
StonvexStonvexStonvexCore line items from AME's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.40B | $6.94B | $6.60B | $6.15B |
Operating Income | $1.91B | $1.78B | $1.71B | $1.50B |
Net Income | $1.48B | $1.38B | $1.31B | $1.16B |
EPS (Diluted) | $6.40 | $5.93 | $5.67 | $5.01 |
Total Assets | $16.07B | $14.63B | $15.02B | $12.43B |
Total Liabilities | $5.44B | $4.98B | $6.29B | $4.95B |
Cash & Equivalents | $457.95M | $374.00M | $409.80M | $345.39M |
Free Cash Flow OCF − CapEx | $1.67B | $1.70B | $1.60B | $1.01B |
Shares Outstanding | 229.00M | 230.70M | 230.90M | 230.10M |